Based on five prognostic variables (age, serum β2-microglobulin, clinical stage, IGHV mutational status, and TP53 status), the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) categorized patients with CLL into four risk groups. Here, HLA-G is linked to B-cell chronic lymphocytic leukemia.